# PURETHAL Grasses Rush Study

> **NCT01059266** · PHASE4 · COMPLETED · sponsor: **HAL Allergy** · enrollment: 150 (actual)

## Conditions studied

- Allergic Rhinitis
- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** PURETHAL Grasses, 20.000 AUM/ml

## Key facts

- **NCT ID:** NCT01059266
- **Lead sponsor:** HAL Allergy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2012-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01059266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01059266, "PURETHAL Grasses Rush Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01059266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*